Login / Signup

The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies.

Xiuzhu HouJing LiuTiancheng WangJiansuo ZhouLiyan Cui
Published in: Journal of clinical laboratory analysis (2020)
Similar to ELISA, CIA was competent to detect MPO and PR3 antibodies in AAV patients and healthy population, thus distinguish AAV patients from IC group and HC group and effectively diagnose MPA and GPA.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • gene therapy
  • patient reported